0001415889-23-003045.txt : 20230222
0001415889-23-003045.hdr.sgml : 20230222
20230222183706
ACCESSION NUMBER: 0001415889-23-003045
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230217
FILED AS OF DATE: 20230222
DATE AS OF CHANGE: 20230222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALLEN HUBERT L
CENTRAL INDEX KEY: 0001565916
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 23655203
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD, AP6C-1N
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 2246676100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
form4-02222023_110256.xml
X0306
4
2023-02-17
0000001800
ABBOTT LABORATORIES
ABT
0001565916
ALLEN HUBERT L
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064
false
true
false
false
EXECUTIVE VICE PRESIDENT
Common shares without par value
2023-02-17
4
A
0
18448
0
A
185543
D
Option (right to buy)
106.24
2023-02-17
4
A
0
72754
0
A
2024-02-17
2033-02-16
Common Shares
72754
72754
D
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 24,251 on February 17, 2024, 24,251 on February 17, 2025, and 24,252 on February 17, 2026.
/s/ Hubert L. Allen by Jessica H. Paik, Attorney-in-Fact
2023-02-22